← Leaderboards
Bridget K Wagner
Massachusetts Institute Of Technology
$7,850,427
Attributed
$13,667,424
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2008–22$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,667,424 · 7
By mechanism
R01$3,607,326 · 2
U01$3,067,405 · 1
UC4$2,696,088 · 1
DP2$2,607,867 · 1
S10$1,007,348 · 1
DP1$681,390 · 1
Top collaborators
- Amit Choudhary8 shared
- Rohit N. Kulkarni7 shared
- Stephen M Secor5 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Chi-Sang Poon$10,383,721
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeBeta CellInsulin-Dependent Diabetes MellitusCell PhysiologyCell SurvivalBaseScreeningPhenotypeCommunitiesCellular BiologyInsulinIn VivoNatural RegenerationBiologicalDiabetes MellitusPancreasCell DeathCytokineCellsSamplingPhysiologicalPreventApoptosisInsulin Secretion
Grant awards (18)
One-compound, one-islet: A high-throughput platform for small-molecule discovery$746,566
U01 · FY2022 · DK · contact PI
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes$516,861
R01 · FY2022 · DK · contact PI
One-compound, one-islet: A high-throughput platform for small-molecule discovery$761,100
U01 · FY2021 · DK · contact PI
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes$556,766
R01 · FY2021 · DK · contact PI
One-compound, one-islet: A high-throughput platform for small-molecule discovery$765,531
U01 · FY2020 · DK · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$461,308
R01 · FY2020 · DK
Opera Phenix high-throughput microplate confocal imager for high-content screening$1,007,348
S10 · FY2019 · OD · contact PI
One-compound, one-islet: A high-throughput platform for small-molecule discovery$794,208
U01 · FY2019 · DK · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$520,785
R01 · FY2019 · DK
From genes to function to therapeutics: High-throughput functional genomics using a human beta cell model$681,390
DP1 · FY2018 · DK · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$528,239
R01 · FY2018 · DK
Development of small molecule-based methods for targeted cargo delivery to beta cells$2,696,088
UC4 · FY2017 · DK
Leveraging snakes' extreme physiology to modulate human beta-cell function$528,239
R01 · FY2017 · DK
Leveraging snakes' extreme physiology to modulate human beta-cell function$495,128
R01 · FY2016 · DK
Small-molecule approaches to restore glycemic control in type 1 diabetes$85,400
DP2 · FY2010 · DK · contact PI
Small-molecule approaches to restore glycemic control in type 1 diabetes$2,466
DP2 · FY2010 · DK · contact PI
Small-molecule approaches to restore glycemic control in type 1 diabetes$2,177,176
DP2 · FY2008 · DK · contact PI
Small-molecule approaches to restore glycemic control in type 1 diabetes$342,825
DP2 · FY2008 · DK · contact PI